Copyright
©The Author(s) 2022.
World J Gastroenterol. Oct 21, 2022; 28(39): 5735-5749
Published online Oct 21, 2022. doi: 10.3748/wjg.v28.i39.5735
Published online Oct 21, 2022. doi: 10.3748/wjg.v28.i39.5735
Table 3 Comparison of coronavirus disease 2019 pneumonia complications in patients with (group 1) and without (group 2) elevated liver enzymes
| Group 1 | Group 2 | P value | |
| Bacterial complication, n/% | 335/55.6 | 34/42.0 | 0.0213 |
| Sepsis, n/% | 14/2.3 | 4/4.9 | 0.1672 |
| Respiratory failure, n/% | 63/10.4 | 7/8.6 | 0.6146 |
| Acid-alkaline imbalance, n/% | 11/1.8 | 0 | 0.2204 |
| Electrolyte imbalance, n/% | 67/11.1 | 8/9.9 | 0.7385 |
| Hyperkalemia, n/% | 10/1.7 | 0 | 0.2426 |
| Hypokalemia, n/% | 40/6.6 | 7/8.6 | 0.5023 |
| Hypernatremia, n/% | 1/0.2 | 2/2.5 | 0.0032 |
| Hyponatremia, n/% | 13/2.2 | 0 | 0.1821 |
| Blood volume decrease, n/% | 15/2.5 | 3/3.7 | 0.5209 |
| Blood clotting disorder, n/% | 6/1.0 | 3/3.7 | 0.0446 |
| Acute kidney failure, n/% | 15/2.5 | 1/1.2 | 0.4836 |
| Acute liver failure, n/% | 5/0.8 | 0 | 0.3672 |
| Antibiotic resistance, n/% | 18/3.0 | 1/1.2 | 0.3681 |
- Citation: Liakina V, Stundiene I, Milaknyte G, Bytautiene R, Reivytyte R, Puronaite R, Urbanoviciute G, Kazenaite E. Effects of COVID-19 on the liver: The experience of a single center. World J Gastroenterol 2022; 28(39): 5735-5749
- URL: https://www.wjgnet.com/1007-9327/full/v28/i39/5735.htm
- DOI: https://dx.doi.org/10.3748/wjg.v28.i39.5735